A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

SBL03 was formulated as an ophthalmic gel for non-invasive topical delivery. Its unique ability to infiltrate eye tissues effectively and protect ret ...

If it’s been more than four hours and your hard-on isn’t going away, you could be suffering from priapism. It’s a serious ...

SIL-204 administered in an extended release formulation reduced tumor growth by ~50% after 30 days, with ~50% of tumors showing complete necrosis, in human pancreatic tumors harboring a G12D mutation ...

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps ...

Studies show cell-free DNA (cfDNA), including cf-nDNA and cf-mtDNA, is released during stress, offering a potential biomarker ...

Cell growth usually refers to cell proliferation, the increase in cell numbers that occurs through repeated cell division. Cell growth can also refer to the enlargement of cell volume, which can ...

Osteomyelitis, a bone infection caused by bacterial or fungal spread, leads to painful swelling and potential bone loss if ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Nanjing Reju Therapeutics Inc. has described tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD) inhibitors reported to be useful for the treatment of inflammatory-related ...

A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, ...